The Goldman Sachs Group, Inc. 13D and 13G filings for Rapport Therapeutics, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-06-24 9:00 pm Sale | 2024-06-13 | 13G | Rapport Therapeutics, Inc. Common Stock RAPP | GOLDMAN SACHS GROUP INC GS | 1,285,188 3.500% | -1,380,494 (-51.79%) | Filing |
| 2024-06-21 4:52 pm Purchase | 2024-06-11 | 13G | Rapport Therapeutics, Inc. Common Stock RAPP | GOLDMAN SACHS GROUP INC GS | 2,665,682 7.500% | 2,665,682 (New Position) | Filing |